In 2012 the European Cardiovascular Research Institute (ECRI) was founded as a European collaborative effort to perform Investigator Sponsored Studies in the field of cardiology.
Talent - Study purpose
TALENT
Thin strut sirolimus-eluting stent in All comers population vs Everolimus-eluting stent
A prospective multicenter randomized post market all-comer trial to assess the safety and effectiveness of the SUPRAFLEX sirolimus-eluting coronary stent system for the treatment of atherosclerotic lesion(s).
To compare the SUPRAFLEX SES with the XIENCE EES with respect to target lesion failure (TLF) at 12 months in a non-inferiority trial in a “real world” patient population